Entera Bio Ltd.

NASDAQ: ENTX · Real-Time Price · USD
1.99
0.02 (1.02%)
At close: Aug 15, 2025, 3:59 PM
2.00
0.50%
After-hours: Aug 15, 2025, 04:10 PM EDT

Entera Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
181K n/a 134K 571K
Cost of Revenue
172K 56K 101K 373K
Gross Profit
9K -56K 33K 198K
Operating Income
-9.59M -8.89M -13.02M -12.22M
Interest Income
n/a 31K 83K n/a
Pretax Income
-9.53M -8.86M -12.93M -12.25M
Net Income
-9.54M -8.89M -13.07M -12.19M
Selling & General & Admin
5.09M 4.43M 7.25M 5.69M
Research & Development
4.5M 4.51M 5.85M 6.77M
Other Expenses
n/a n/a -51K -46K
Operating Expenses
9.59M 8.88M 13.05M 12.41M
Interest Expense
n/a n/a n/a 29K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
9.77M 8.94M 13.15M 12.79M
Income Tax Expense
14K 29K 137K -59K
Shares Outstanding (Basic)
37.65M 29.01M 28.81M 26.13M
Shares Outstanding (Diluted)
37.65M 29.01M 28.81M 26.13M
EPS (Basic)
-0.25 -0.31 -0.45 -0.47
EPS (Diluted)
-0.25 -0.31 -0.45 -0.47
EBITDA
-9.54M -8.8M -12.87M -12.16M
EBIT
-9.59M -8.86M -13.02M -12.22M
Depreciation & Amortization
46K 56K 64K 53K